Steven Cohen Wave Life Sciences Ltd. Transaction History

Point72 Asset Management, L.P.

$36 Billion
Q2 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 115,478 shares of WVE stock, worth $957,312. This represents 0.0% of its overall portfolio holdings.

Number of Shares

115,478

Previous 115,478 -0.0%

Holding current value

$957,312

Previous $576,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.38 - $6.48 $8.14 Million - $12 Million	-1,859,259 Reduced 94.15%	115,478 $576,000
Q1 2024 May 15, 2024	SELL	$3.54 - $6.84 $4.39 Million - $8.47 Million	-1,238,763 Reduced 38.55%	1,974,737 $12.2 Million
Q4 2023 Feb 14, 2024	BUY	$4.16 - $6.87 $13.4 Million - $22.1 Million	3,213,500 New	3,213,500 $16.2 Million
Q1 2023 May 15, 2023	SELL	$3.58 - $6.3 $171,124 - $301,140	-47,800 Reduced 75.16%	15,800 $68,000
Q4 2022 Feb 14, 2023	SELL	$3.18 - $7.0 $3.09 Million - $6.79 Million	-970,600 Reduced 93.85%	63,600 $445,000
Q3 2022 Nov 14, 2022	BUY	$2.37 - $4.28 $2.45 Million - $4.43 Million	1,034,200 New	1,034,200 $3.73 Million
Q2 2021 Aug 16, 2021	SELL	$5.65 - $7.47 $4.8 Million - $6.34 Million	-849,109 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.61 - $12.01 $4.76 Million - $10.2 Million	849,109 New	849,109 $4.76 Million
Q3 2020 Nov 16, 2020	SELL	$8.49 - $19.54 $2.43 Million - $5.59 Million	-286,116 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.44 - $11.29 $2.13 Million - $3.23 Million	286,116 New	286,116 $2.98 Million
Q1 2020 May 15, 2020	SELL	$6.94 - $14.22 $1.1 Million - $2.25 Million	-158,400 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.99 - $37.6 $906,066 - $4.26 Million	113,400 Added 252.0%	158,400 $1.27 Million
Q3 2019 Nov 15, 2019	BUY	$19.17 - $27.4 $28,755 - $41,100	1,500 Added 3.45%	45,000 $924,000
Q2 2019 Aug 14, 2019	SELL	$22.93 - $42.84 $12.4 Million - $23.1 Million	-538,811 Reduced 92.53%	43,500 $1.14 Million
Q1 2019 May 15, 2019	BUY	$32.69 - $47.91 $3.02 Million - $4.43 Million	92,499 Added 18.88%	582,311 $22.6 Million
Q4 2018 Feb 14, 2019	BUY	$37.1 - $50.11 $3.33 Million - $4.5 Million	89,812 Added 22.45%	489,812 $20.6 Million
Q3 2018 Nov 14, 2018	BUY	$36.35 - $55.2 $1.82 Million - $2.76 Million	50,000 Added 14.29%	400,000 $20 Million
Q2 2018 Aug 14, 2018	BUY	$33.85 - $50.65 $10.4 Million - $15.6 Million	307,700 Added 727.42%	350,000 $13.4 Million
Q1 2018 May 15, 2018	SELL	$32.45 - $54.7 $1.87 Million - $3.16 Million	-57,700 Reduced 57.7%	42,300 $1.7 Million
Q4 2017 Feb 14, 2018	SELL	$21.8 - $39.35 $11.5 Million - $20.8 Million	-528,912 Reduced 84.1%	100,000 $3.51 Million
Q3 2017 Nov 14, 2017	BUY	$16.4 - $25.05 $10.3 Million - $15.8 Million	628,912	628,912 $13.7 Million

Others Institutions Holding WVE

# of Institutions

146

Shares Held

93.1M

Call Options Held

33K

Put Options Held

57.2K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $720M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account